|
a polygenic disease characterized by abnormally high glucose levels in the blood; any of several metabolic disorders marked by excessive urination ...
|
Author:
Yngve, Agneta
Page:
971-972
]]>
Author:
Hughes, Roger
Page:
973
]]>
Author:
Cannon, Geoffrey
Page:
974-977
]]>
Author:
Lund, Vivien *; Stockley, Lynn; Levy, Louis
Page:
978-979
]]>
Author:
Gibson, Sigrid; on behalf of the Food Standards Agency
Page:
980-988
]]>
Author:
Oddy, W H 1,2; Miller, M 1; Payne, J M 1; Serna, P 1; Bower, C I 1,3,*
Page:
989-995
]]>
Author:
Senarath, Upul 1; Dibley, Michael J 2,*+; Agho, Kingsley E 3
Page:
996-1004
]]>
Author:
Giskes, Katrina 1,2,*; Kamphuis, Carlijn BM 2; van Lenthe, Frank J 2; Kremers, Stef 3; Droomers, Mariel 4; Brug, Johannes 2
Page:
1005-1017
]]>
Author:
Granado, F *; Blazquez, S and; Olmedilla, B +
Page:
1018-1023
]]>
Author:
Cowburn, Gill *; Boxer, Anna
Page:
1024-1031
]]>
Author:
Assey, Vincent D 1,2,*; Mgoba, Celestin 1; Mlingi, Nicholaus 1; Sanga, Alfred 1; Ndossi, Godwin D 1; Greiner, Ted 2,+; Peterson, Stefan 3,4
Page:
1032-1038
]]>
Author:
Madanat, Hala N 1,2,*; Brown, Ralph B 3; Hawks, Steven R 2
Page:
1039-1046
]]>
Author:
Mamabolo, R L 1,*; Kruger, H S 1; Lennox, A 2; Monyeki, M A 2; Pienaar, A E 2; Underhay, C 2; Czlapka-Matyasik, M 1
Page:
1047-1056
]]>
Author:
Smith, Albert F 1,*; Baxter, Suzanne Domel 2; Hardin, James W 3; Guinn, Caroline H 2; Royer, Julie A 2; Litaker, Mark S 4
Page:
1057-1066
]]>
Author:
Liu, Jian 1,*; Sempos, Christopher 2
Page:
1067-1076
]]>
Author:
Silvera, Stephanie AN 1,*; Jain, Meera 2; Howe, Geoffrey R 3; Miller, Anthony B 2; Rohan, Thomas E 4
Page:
1076-1081
]]>
Author:
Hendricks, M 1,*; Beardsley, J 2; Bourne, L 3; Mzamo, B 1,3; Golden, B 2
Page:
1082-1088
]]>
Author:
Su, Dada 1; Zhao, Yun 1; Binns, Colin 1,*; Scott, Jane 2; Oddy, Wendy 1
Page:
1089-1093
]]>
Author:
Hjartaker, Anette 1,2,*,+; Andersen, Lene Frost 3; Lund, Eiliv 2
Page:
1094-1103
]]>
Author:
Knudsen, Vibeke K 1,*; Hansen, Harald S 2; Ovesen, Lars 3; Mikkelsen, Tina B 1; Olsen, Sjurour F 1
Page:
1104-1110
]]>
|
|
Treatment Of Diabetes
By Hans
| Now a day's treatment has become a common disease among people. It is caused due to mismanagement of carbohydrate metabolism inside the body. is identified with the excessive production of urine, hunger, thirst and excessive loss of weight, blurred vision, and delay in healing of skin, repeated infection, and excessive fatigue. Now a day's treatment has become a common disease among people. It is caused due to mismanagement of carbohydrate metabolism inside the body. is identified with the excessive production of urine, hunger, thirst and excessive loss of weight, blurred vision, and delay in healing of skin, repeated infection, and excessive fatigue. has got a serous issue of human health. It denotes sugar in blood and urine very excessively. So, when it comes to treatment of the main concern should be given to control blood sugar, which is main cause of diabetes. Managing blood sugar is the stepping-stone of this treatment program. To remove the complications of one must take it seriously and adopt some good diet process or healthy exercise. Apart from doing so some take insulin and any other type of medication program to be cured to some extent. Frequent testing of blood sugar can denote you how much you have improved on your part to manage suitable measure of sugar in blood. It is very important to learn the right range of glucose in blood unless and until you cannot have the idea about the complication you are facing about this disease. It depends on age mainly such as in younger age assuming not much complication is there the suitable range of glucose is 80-120 mg/dL and in older age it is 100-140 mg/dL.
Increasing Soda Consumption Fuels Rise in Diabetes, Heart
Disease (HealthDay)HealthDay - FRIDAY, March 5 (HealthDay News) --Increasing consumption of sugary
soft drinks contributed to 130,000 new cases of diabetes, 14,000 new cases
of heart disease and 50,000 more life-years burdened with heart disease in
the last decade, a new U.S. study finds.Processed Meat May Harm the Heart (HealthDay)HealthDay - FRIDAY, March 5 (HealthDay News) -- Conventional wisdom has dictated
that fat from red meat is a risk factor for heart disease, but a new
analysis from Harvard researchers finds it's eating processed meat -- not
unprocessed red meat -- that increases the risk for heart disease and even
diabetes.Bugs in the gut can cause obesity: study (AFP)AFP - The bugs that help digest food may also cause the body to pack on the pounds if they are not properly regulated, a new study has found.Bugs in the gut can cause obesity: study (AFP)AFP - The bugs that help digest food may also cause the body to pack on the pounds if they are not properly regulated, a new study has found.Lunchtime coffee break best for fighting diabetes (Reuters)Reuters - Drinking coffee cuts diabetes risk, new research confirms, but you may need to enjoy your java with lunch if you want to get any benefit.Whole Grains Take a Bite Out of Type 2 Diabetes Risk (HealthDay)HealthDay - WEDNESDAY, March 3 (HealthDay News) -- Brown rice is better than white
rice at reducing the risk of type 2 diabetes, but whole grains are the
most effective at lowering the risk, study findings show.A1c diabetes test is a better indicator of risk (Reuters)Reuters - A test that shows blood sugar levels over a span of several weeks is not only the best way to diagnose diabetes but also may be better at identifying who is at risk of getting diabetes than standard blood sugar tests, researchers said on Wednesday.Newer Blood Test Predicts Diabetes, Heart Disease (HealthDay)HealthDay - WEDNESDAY, March 3 (HealthDay News) -- The newer hemoglobin A1C
test predicts diabetes as well as the traditional fasting blood sugar
test, but it beats that old standard in predicting a patient's future risk
of heart disease and stroke, new research shows.Having Prediabetes May Not Kick-Start Prevention Efforts (HealthDay)HealthDay - TUESDAY, March 2 (HealthDay News) -- Knowing you're on the cusp of
developing diabetes apparently isn't enough to make most people take steps
to prevent it.Scientists try to break fat-and-disease link (AP)AP - What if you could be fat but avoid heart disease or diabetes? Scientists trying to break the fat-and-disease link increasingly say inflammation is the key.
Diabetes program includes some specific self-treatments like having good and suitable diet, having proper exercise, maintaining healthy weight and medication. When it is about good and suitable diet it does not make any suggestion to take all dull food which are not of your interest rather it denotes to have more fruits, vegetables and grains that means you should be conscious in taking the foods of high nutrition and lower fat and calories. Avoid taking sweets and animal products with no limit. The main part of this treatment program is that you own self should be challenging in this task otherwise this program will be harder enough. Consult any dietitian about meal plan and try to maintain it at the fixed times every day with same amount according to your diet plan. On the part of having proper exercise you should be cautious about all aerobic exercises. In this treatment program you can make your choices among the daily exercises like doing morning or evening walk, jogging, hiking, biking, swimming and any other exercises of heart and lungs. Remember giving consistency to your exercise process is very important to get the best result through it. Try to maintain weight according to your activity level and age because overweight is dangerous factor which help to make your cells more resistant to insulin. Making suitable weight loss plan and going according to that can make its result more effectively. Sometimes medication takes a very important role in case where it is found that good dieting and exercise are not fulfilling it purpose. This type of program includes the insert of insulin as per requirement. As it can't be taken in form of pill some people have it injected by syringe or some have it with insulin pump. So now it is very clear that is always manageable if the sufferer give a serious daily attention to it. Although stands for life long suffering, yet it never means the end of your life. You just have to remember that the disease will be in your control only and only if you are self disciplined for your each and every step of treatment program. DISCLAIMER: This information is not presented by a medical practitioner and is for educational and informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read. Since natural and/or dietary supplements are not FDA approved they must be accompanied by a two-part disclaimer on the product label: that the statement has not been evaluated by FDA and that the product is not intended to "diagnose, treat, cure or prevent any disease."
Here are some more diabetes articles...
Is A Natural Cure For Diabetes A Possible Alternative?
By Flor Serquina
Having diabetes is akin to walking a tightrope - you have to face the challenge of ensuring that you don't get too little sugar in your bloodstream and also that you don't get too much. This, you Read more...
|
Diabetes Care For A Normal Life
By ravi agrawal
With the realisation that you suffer from diabetes, comes the need to educate yourself about the disease. The line of treatment for diabetes is such that you need to be self-dependent and take proper Read more...
|
Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
<b>Conditions</b>: Type 2 Diabetes; Hypogonadism<br/><b>Intervention</b>: Drug: Testosterone<br/><b>Sponsor</b>: Tameside Hospital NHS Foundation Trust<br/><b>Not yet recruiting</b> - verified November 2008
Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes
<b>Condition</b>: Type 1 Diabetes Mellitus<br/><b>Interventions</b>: Behavioral: Diabetes related psychological counseling and education; Device: Continuous Glucose Monitor<br/><b>Sponsors</b>: University Hospital Case Medical Center; National Institute of Mental Health (NIMH)<br/><b>Not yet recruiting</b> - verified March 2010
Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes
<b>Condition</b>: Diabetes Mellitus, Type 2<br/><b>Interventions</b>: Drug: linagliptin; Drug: placebo<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Recruiting</b> - verified March 2010
To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656
<b>Condition</b>: Type 2 Diabetes Mellitus<br/><b>Interventions</b>: Drug: AZD1656; Drug: Gemfibrozil; Drug: Placebo<br/><b>Sponsor</b>: AstraZeneca<br/><b>Not yet recruiting</b> - verified March 2010
Effects of Caloric Restriction Alone Versus Postoperative Caloric Restriction Following Bariatric Surgery on Glucose Metabolism in Patients With Diabetes Mellitus
<b>Conditions</b>: Obesity; Bariatric Surgery; Morbid Obesity; Diabetes Mellitus Type 2; Diet Therapy<br/><b>Interventions</b>: Procedure: Roux-en-Y Gastric Bypass; Behavioral: Caloric Restriction<br/><b>Sponsor</b>: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified February 2010
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus
<b>Condition</b>: Type 2 Diabetes Mellitus<br/><b>Interventions</b>: Drug: AZD1656; Drug: Pioglitazone<br/><b>Sponsor</b>: AstraZeneca<br/><b>Recruiting</b> - verified March 2010
The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial
<b>Condition</b>: Diabetes Mellitus, Type 2<br/><b>Interventions</b>: Drug: Canagliflozin 100 mg; Drug: Placebo/sitagliptin 2x50 mg; Drug: Canagliflozin 300 mg<br/><b>Sponsor</b>: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.<br/><b>Recruiting</b> - verified March 2010
Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition
<b>Condition</b>: Diabetes Mellitus, Type 2<br/><b>Interventions</b>: Drug: INSULIN GLARGINE; Drug: INSULIN GLULISINE<br/><b>Sponsor</b>: Sanofi-Aventis<br/><b>Recruiting</b> - verified March 2010
Comparing Google With A Focused Diabetes Search Engine
<b>Condition</b>: Diabetes<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Beth Israel Deaconess Medical Center<br/><b>Recruiting</b> - verified March 2010
Continuous Glucose Monitoring in Type 2 Diabetes Mellitus
<b>Condition</b>: Diabetic Vascular Complications<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Winthrop University Hospital<br/><b>Recruiting</b> - verified March 2010
Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes
<b>Condition</b>: Diabetes Mellitus, Type 1<br/><b>Interventions</b>: Drug: NN1250; Drug: insulin glargine; Drug: NN1250; Drug: insulin aspart<br/><b>Sponsor</b>: Novo Nordisk<br/><b>Recruiting</b> - verified March 2010
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
<b>Conditions</b>: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Polyneuropathy<br/><b>Interventions</b>: Drug: SB-509; Other: Saline<br/><b>Sponsors</b>: Sangamo Biosciences; Juvenile Diabetes Research Foundation<br/><b>Recruiting</b> - verified March 2010
Corneal Endothelial Changes Associated With Phacoemulsification in Diabetes Mellitus Type II
<b>Conditions</b>: Diabetes; Cataract<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Frederiksberg University Hospital<br/><b>Completed</b> - verified August 2009
Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus
<b>Condition</b>: Hypertension<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Abbott<br/><b>Completed</b> - verified March 2010
Impact of Computerized Decision Support on Racial/Ethnic Disparities in Hypertension Outcomes
<b>Condition</b>: Hypertension<br/><b>Intervention</b>: Other: Computerized reminders on hypertension intensification<br/><b>Sponsors</b>: Brigham and Women's Hospital; Robert Wood Johnson Foundation<br/><b>Not yet recruiting</b> - verified March 2010
Intraarterial Infusion of Autologous Mesenchymal Stem Cells From Adipose Tissue in Diabetic Patients With Chronic Critical Limb Ischemia
<b>Conditions</b>: Diabetes; Limb Ischemia<br/><b>Interventions</b>: Other: Autologous mesenchymal stem cells from adipose tissue.; Other: Autologous mesenchymal stem cells from adipose tissue.; Other: Autologous mesenchymal stem cells from adipose tissue.<br/><b>Sponsors</b>: Fundacion Progreso y Salud, Spain; Carlos III Health Institute<br/><b>Recruiting</b> - verified January 2010
Reducing HIV Risk Among Mexican Youth
<b>Conditions</b>: HIV/AIDS; STD; Sexual Behavior<br/><b>Interventions</b>: Behavioral: Adolescent Safer Sex Intervention; Behavioral: Parent Safer Sex Communication Intervention; Other: Adolescent Health Promotion Control Condition; Other: Parent Health Promotion Control Condition<br/><b>Sponsors</b>: University of Michigan; National Institute of Nursing Research (NINR)<br/><b>Completed</b> - verified March 2010
Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects
<b>Conditions</b>: Genotype; Pharmacokinetic<br/><b>Intervention</b>: Drug: Glipizide<br/><b>Sponsors</b>: Chinese Academy of Sciences; The First Affiliated Hospital of Lanzhou University<br/><b>Completed</b> - verified November 2009
Role of Vitagliptin and Vitamin D in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)
<b>Condition</b>: Non-Alcoholic Fatty Liver Disease<br/><b>Interventions</b>: Drug: Galvus (vitagliptin); Drug: Galvus + vitamin D<br/><b>Sponsor</b>: Ziv Hospital<br/><b>Not yet recruiting</b> - verified March 2010
Adolescent Cooking and Eating Study
<b>Condition</b>: Polycystic Ovary Syndrome<br/><b>Intervention</b>: Behavioral: Nutrition Education, Dietary Counseling, and Cooking<br/><b>Sponsors</b>: Children's Hospital Boston; Thrasher Research Fund<br/><b>Not yet recruiting</b> - verified March 2010
Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot Feet
<b>Conditions</b>: Diabetes Mellitus 1 or 2; Midfoot Charcot Neuroarthropathy<br/><b>Interventions</b>: Procedure: Surgery with Midfoot Fusion Bolt; Procedure: Cast treatment<br/><b>Sponsor</b>: AO Clinical Investigation and Documentation<br/><b>Not yet recruiting</b> - verified March 2010
An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients
<b>Condition</b>: Diabetes Mellitus, Type 2<br/><b>Intervention</b>: Drug: repaglinide<br/><b>Sponsor</b>: Novo Nordisk<br/><b>Not yet recruiting</b> - verified February 2010
Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment.
<b>Condition</b>: Diabetes Type 2<br/><b>Interventions</b>: Drug: Insulin-Levemir; Drug: Exenatide-Bayetta; Drug: Insulin-Levemir and Exenatide-Bayetta; Device: SenseWear Pro3® armband; Device: DexCom CGM<br/><b>Sponsors</b>: Novo Nordisk; BodyMedia<br/><b>Recruiting</b> - verified June 2009
Effects of a Spiced Meat Patty on Inflammation in Men With Type 2 Diabetes
<b>Condition</b>: Type II Diabetes Mellitus<br/><b>Intervention</b>: Other: Spice polyphenols<br/><b>Sponsor</b>: University of California, Los Angeles<br/><b>Recruiting</b> - verified February 2010
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
<b>Condition</b>: Diabetes Mellitus, Type 2<br/><b>Interventions</b>: Drug: NN1250; Drug: insulin glargine<br/><b>Sponsor</b>: Novo Nordisk<br/><b>Recruiting</b> - verified March 2010
A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents
<b>Condition</b>: Type 2 Diabetes<br/><b>Interventions</b>: Drug: exenatide; Drug: Other antidiabetic therapies; Other: No diabetes therapy<br/><b>Sponsors</b>: Amylin Pharmaceuticals, Inc.; Eli Lilly and Company<br/><b>Completed</b> - verified February 2010
Ranibizumab for Edema of the mAcula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
<b>Condition</b>: Diabetic Macular Edema<br/><b>Interventions</b>: Drug: Ranibizumab; Drug: ranibizumab<br/><b>Sponsors</b>: Johns Hopkins University; Juvenile Diabetes Research Foundation<br/><b>Recruiting</b> - verified February 2010
BASAAL PLUS - Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting
<b>Condition</b>: Diabetes Mellitus, Type 2<br/><b>Interventions</b>: Drug: Insulin glulisine; Drug: Insulin glargine; Drug: Premixed insulin (Insulin Aspart 30/70 )<br/><b>Sponsor</b>: Sanofi-Aventis<br/><b>Recruiting</b> - verified March 2010
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia
<b>Conditions</b>: Schizophrenia; Schizoaffective Disorders; Schizophreniform Disorders<br/><b>Interventions</b>: Drug: Pravastatin; Drug: Placebo<br/><b>Sponsors</b>: Massachusetts General Hospital; Stanley Medical Research Institute<br/><b>Not yet recruiting</b> - verified March 2010
DETECT-Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment
<b>Condition</b>: Cardiovascular Diseases<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Dresden University of Technology; Johann Wolfgang Goethe University Hospitals; Max-Planck-Institute of Psychiatry; University of Magdeburg; Medical University of Graz; Universitätsklinikum Hamburg-Eppendorf<br/><b>Completed</b> - verified February 2010
Healthy Homes/Healthy Kids_5-9
<b>Conditions</b>: Obesity; Injury<br/><b>Interventions</b>: Behavioral: Healthy Eating/Physical Activity; Behavioral: Safety/Injury Prevention<br/><b>Sponsors</b>: HealthPartners Research Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Washington; University of Minnesota School of Public Health<br/><b>Not yet recruiting</b> - verified March 2010
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients
<b>Condition</b>: Hypertension<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Abbott; McKesson Canada<br/><b>Recruiting</b> - verified February 2010
Pilot Pharmacokinetic Study of Daily Versus Monthly High-Dose Cholecalciferol Supplementation
<b>Condition</b>: Healthy Volunteers<br/><b>Interventions</b>: Dietary Supplement: Single High Dose Cholecalciferol; Dietary Supplement: Daily Dose Cholecalciferol<br/><b>Sponsor</b>: Mayo Clinic<br/><b>Recruiting</b> - verified March 2010
Effects of N-acetylcysteine on Diabetic Foot Oxygenation
<b>Condition</b>: Foot Ulcer, Diabetic<br/><b>Intervention</b>: Drug: N-acetylcysteine<br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Completed</b> - verified February 2010
Self Management and Reminders With Technology: SMART Appraisal of an Integrated Personal Health Record (PHR)
<b>Condition</b>: Cardiovascular Risk<br/><b>Interventions</b>: Other: SMART PHR; Other: usual care<br/><b>Sponsors</b>: University of Pittsburgh; Agency for Healthcare Research and Quality (AHRQ)<br/><b>Not yet recruiting</b> - verified March 2010
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use NSAIDs and/or Colchicines.
<b>Condition</b>: Acute Gout<br/><b>Interventions</b>: Drug: ACZ885; Drug: Triamcinolone acetonide<br/><b>Sponsor</b>: Novartis Pharmaceuticals<br/><b>Not yet recruiting</b> - verified March 2010
Documentation of Humira in Psoriasis Patients in Routine Clinical Practice
<b>Condition</b>: Moderate to Severe Plaque Psoriasis<br/><b>Intervention</b>: Biological: adalimumab (Humira)<br/><b>Sponsor</b>: Abbott<br/><b>Recruiting</b> - verified February 2010
Healthy Homes/Healthy Kids Preschool
<b>Condition</b>: Obesity<br/><b>Interventions</b>: Behavioral: Busy Bodies/Better Bites; Behavioral: Healthy Spots/Safe Tots<br/><b>Sponsors</b>: HealthPartners Research Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Not yet recruiting</b> - verified March 2010
Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices
<b>Condition</b>: Esophageal Varices<br/><b>Intervention</b>: Device: Capsule endoscopy, Esophagogastroduodenoscopy<br/><b>Sponsors</b>: University of California, Los Angeles; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Completed</b> - verified June 2008
Study of Ischemic Colitis Compared to Other Diagnoses in Patients With Lower Gastrointestinal Bleeding
<b>Condition</b>: Colitis, Ischemic<br/><b>Intervention</b>: <br/><b>Sponsors</b>: University of California, Los Angeles; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Completed</b> - verified December 2009
|
|
|
Resources |
The Research Proven Supplements For Adult-onset Diabetes (type
By Brian B. Carter, MS, LAc, Thu Dec 8th
Q: What are some good herbs for diabetes?Answer: All of the following info is based on research. See thereferences at the end of the article.Typical Western (M.D.) Diabetes Read more...
|
|
|
